Stock listing

NASDAQ:SNTI Senti Biosciences Holdings, Inc. Stock

Home listing (NASDAQ) of Senti Biosciences Holdings, Inc.

Follow Senti Biosciences Holdings, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:SNTI

$1.77 USD -1.02 (-36.6%)

Close on Nov 20, 2026

Past year -97.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.71 – $2.59 USDNov 20, 2026
Volume
39,024 sharesNov 20, 2026
Market cap
$2.06M USDAt the close on Nov 20, 2026 · price × 1.17M shares outstanding
52-week range
$1.71 – $95.04 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$24,965 USDMedian day 252 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Senti Biosciences Holdings, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:SNTI · Home$1.77 USD-1.02 (-36.6%)39,024$2.58$2.59$1.71$2.79Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:SNTI · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.77-1.02-36.6%$2.58$2.59$1.7139,024
$2.79-0.081-2.8%$2.85$3.015$2.5050,083
$2.871-0.33-10.3%$3.102$3.201$2.805437
$3.201-1.287-28.7%$3.666$3.808$2.97563
$4.488-0.132-2.9%$4.607$5.013$4.389502
$4.62-0.231-4.8%$4.851$5.148$4.6277
$4.851-0.33-6.4%$5.082$5.247$4.818139
$5.181+0.528+11.3%$4.587$5.247$4.587205
$4.653-0.594-11.3%$5.181$5.445$4.554316
$5.247-0.033-0.6%$5.28$5.412$5.082213
$5.28-0.165-3.0%$5.115$5.478$5.115160
$5.445-0.396-6.8%$5.709$5.709$5.082263
$5.841-0.033-0.6%$6.006$6.006$5.28382
$5.874-0.33-5.3%$6.072$6.171$5.709241
$6.204+0.759+13.9%$5.676$6.732$5.148820
$5.445-1.716-24.0%$5.709$6.60$5.0161,470
$7.161+0.066+0.9%$7.062$7.854$6.8311,677
$7.095+0.924+15.0%$5.973$7.623$5.9739,176
$6.171+0.396+6.9%$5.544$6.435$5.14880,320
$5.775-0.429-6.9%$6.138$6.138$5.64365,119
$6.204-0.099-1.6%$6.105$6.237$5.61336
$6.303-0.891-12.4%$6.93$7.062$6.138183
$7.194-0.33-4.4%$7.293$7.293$6.93230
$7.524+0.033+0.4%$7.062$7.59$6.963267
$7.491+0.066+0.9%$7.194$7.722$7.062276
$7.425-1.221-14.1%$8.184$8.349$6.9963,214
$8.646+0.693+8.7%$7.92$8.646$7.9217,437
$7.953-0.462-5.5%$8.349$8.646$7.92153
$8.415-2.112-20.1%$10.23$10.26$8.316278
$10.53+0.165+1.6%$10.26$10.63$10.23131
$10.36-0.264-2.5%$10.69$10.69$10.23101
$10.63-0.264-2.4%$10.33$10.86$10.33227
$10.89+0.231+2.2%$10.33$11.55$10.33304
$10.66-0.726-6.4%$10.73$11.22$10.30187
$11.38+0.759+7.1%$10.23$11.38$10.23347
$10.63-0.066-0.6%$10.40$10.76$10.23114
$10.69+0.396+3.8%$10.40$11.06$9.90563
$10.30+0.132+1.3%$10.03$10.43$10.0377
$10.16-0.066-0.6%$10.26$11.12$9.933268
$10.23-0.627-5.8%$10.89$11.22$10.23504
$10.86-0.462-4.1%$10.56$11.12$10.07845
$11.32+0.165+1.5%$11.55$12.21$10.922,116
$11.15+0.726+7.0%$10.89$11.88$10.639,521
$10.43+0.198+1.9%$10.33$11.35$10.26169
$10.23-0.33-3.1%$10.56$10.69$10.2395
$10.56+0.231+2.2%$10.56$10.82$10.07195
$10.33+0.066+0.6%$10.49$10.86$9.933285
$10.26+0.363+3.7%$10.13$10.96$9.575,771
$9.90-0.066-0.7%$9.90$10.59$9.603198
$9.966-0.132-1.3%$10.23$10.23$9.96628
$10.10+0.198+2.0%$9.90$10.56$9.90103
$9.90+0.033+0.3%$10.43$10.43$9.669107
$9.867-0.561-5.4%$10.66$10.66$9.57136
$10.43-0.561-5.1%$10.99$11.22$10.23400
$10.99-0.264-2.3%$11.55$11.88$10.92122
$11.25-0.033-0.3%$12.18$12.47$11.2539
$11.29+0.066+0.6%$11.25$11.95$11.2536
$11.22-1.254-10.1%$12.54$12.54$11.2266
$12.47+0.033+0.3%$12.01$12.67$11.8822
$12.44-0.033-0.3%$12.90$13.13$12.0583
$12.47-0.264-2.1%$12.77$13.13$11.65131
$12.74-0.165-1.3%$12.94$13.20$12.2168
$12.90+0.429+3.4%$12.54$13.27$12.18164
$12.47-0.363-2.8%$12.54$12.84$10.92694
$12.84-1.551-10.8%$14.39$14.52$11.88696
$14.39-0.891-5.8%$15.28$15.48$14.3992

Splits

2 splits since 2024 · NASDAQ:SNTI · every price before a split is adjusted for it

DayRatioWhat
1-for-33Consolidation
1-for-10Consolidation
Ticker
NASDAQ:SNTI
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

Senti Bio Announces Reverse Stock Split

Nov 17, 2026

Closed $3.20 (-28.7%) on Nov 17, 2026

All Senti Biosciences Holdings, Inc. news

Senti Biosciences Holdings, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
18 in the last 12 months · 85 in all · newest Nov 17, 2026 · oldest 2021
Decks
10 decks · latest Dec 9, 2025

Where Senti Biosciences Holdings, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:SNTI · Home listing · This pageNASDAQUnited StatesUSD
BOATS:SNTIBOATSUnited StatesUSD

Valuation

EV/sales −47.2× against a median of 1.5×: the lowest of 4 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
−$3.49M USD
P/E
Loss
EV/sales
−47.2×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
Negative equity
Gross margin
Revenue too small
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
Negative equity
Beta vs S&P 500
2.91

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Senti Biosciences Holdings, Inc. · NASDAQ:SNTIUS$2.06M−US$3.49Mn/a−47.2×n/an/an/an/a2.91
Ernexa Therapeutics Inc. · NASDAQ:ERNAUS$2.30M−US$2.96Mn/an/an/a0.5×n/a0.1×0.86
Cynata Therapeutics Limited · ASX:CYPUS$2.26MUS$1.66Mn/a1.5×n/an/a−540.4%n/an/a
PharmaCyte Biotech, Inc. · NASDAQ:PMCBUS$2.25M−US$15.59Mn/an/an/a0.1×n/a0.0×1.97
Modus Therapeutics Holding AB · OMXSTO:MODTXUS$2.22MUS$1.00Mn/an/an/a2.2×n/a0.0×n/a
Nuformix PLC · LSE:NFXUS$2.22MUS$1.00Mn/an/an/a1.0×n/a0.0×n/a
Medicus Pharma Ltd. · NASDAQ:MDCXUS$2.18M−US$2.73Mn/an/an/an/an/an/a2.03
CASI Pharmaceuticals, Inc. · OTC:CASIFUS$2.06MUS$38.79Mn/a1.9×n/an/a−218.6%n/a-0.07
Vectus Biosystems Limited · ASX:VBSUS$2.02MUS$50,9461.9×n/an/a1.3×n/a0.2×n/a
Decoy Therapeutics Inc. · NASDAQ:DCOYUS$1.98M−US$6.19Mn/a−11.6×n/a0.4×n/a0.0×1.28
Genprex, Inc. · NASDAQ:GNPXUS$1.94M−US$13.41Mn/an/an/a0.1×n/a0.0×1.08
Median of the othersUS$2.20M−US$1.34M1.9×1.5×0.5×−379.5%0.0×1.18

Forecasts

1 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.

Price target
13.50 USD · Analysts' mean
EPS, year to Dec 2026
-1.04 · 2 analysts
Revenue, year to Dec 2026
50K · 2 analysts

Team and board

Officers

OfficerRole
Jenene ThomasChief Executive Officer
Jay CrossChief Financial Officer

Board

DirectorRole
Bryan BaumDirector
Feng HsiungDirector
Fran SchulzDirector

Events

QuarterResultsShare move
Q3 2026Nov 16, 2026 · After close−28.7%
Q2 2026Aug 14, 2026 · After close−4.2%
Q1 2026May 14, 2026 · Before open+8.0%
Q4 2025Mar 27, 2026−12.4%
Q3 2025Nov 13, 2025 · After close−10.1%
Q2 2025Aug 7, 2025 · Before open−8.9%
Q1 2025May 6, 2025 · After close+0.6%
Q4 2024Mar 20, 2025+1.7%
Q3 2024Nov 15, 2024−10.3%
Q2 2024Aug 9, 2024 · Before open−4.9%
All 20 quarters
QuarterResultsShare move
Q1 2024May 9, 2024 · After close−0.3%
Q4 2023Mar 21, 2024 · After close−6.6%
Q3 2023Nov 14, 2023 · Before open−19.4%
Q2 2023Aug 11, 2023 · Before open+0.1%
Q1 2023May 9, 2023 · After close−8.0%
Q4 2022Mar 22, 2023 · After close+2.5%
Q3 2022Nov 10, 2022 · After close−1.6%
Q2 2022Aug 15, 2022 · After close−2.0%
Q1 2022May 16, 2022 · After close0.0%
Q4 2021Mar 7, 2022−0.2%

Open Events

Decks

DeckKindSlidesDate
Corporate Update (December 2025)Corporate update34 slidesDec 9, 2025
Technical Presentation (April 2025)Technical25 slidesApr 28, 2025
Technical Presentation (December 2024)Technical21 slidesDec 3, 2024
Investor Presentation (January 2023)Investor deck39 slidesJan 27, 2023
Investor Presentation (January 2023)Investor deck35 slidesJan 9, 2023
Investor Presentation (December 2022)Investor deck34 slidesDec 12, 2022
Investor Day (December 2022)Investor day34 slidesDec 12, 2022
Investor Presentation (November 2022)Investor deck34 slidesNov 10, 2022
Investor Presentation (October 2022)Investor deck30 slidesOct 3, 2022
SPAC Merger (December 2021)SPAC merger52 slidesDec 20, 2021

Open Decks

Financings

RaiseDate
Private placement of pIPE financing securities
Made bigger: US$47.6M · upon stockholder approval, warrants to purchase up to an additional 25,069,500 shares… · Leerink Partners
Dealers: Leerink Partners (lead)
Buyers: Celadon Partners (additional investment of approximately $10.0 million; led the PIPE financing); New Enterprise Associates (NEA); Leaps by Bayer; Nantahala Capital; The Red Hook Fund LP
Use of proceeds: Fund continued development of SENTI-202 program and manufacturing ramp-up, other R&D, and general corporate purposes
Jan 6, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Went public as Dynamics Special Purpose Corp., a blank check company (SPAC). Priced at US$10.00 a share on May 25, 2021.

Price
US$10.00 a share
Shares offered
20,000,000 shares of Class A common stock
Offering size
US$200 million
Underwriters' option
Up to 3,000,000 more shares
Underwriter
J.P. Morgan
Shares delivered
On or about May 28, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceApr 2, 2021
Filed publiclyMay 7, 2021
Amended twiceNewest May 24, 2021
Shares registered with an exchangeMay 25, 2021
Declared effective by the SECMay 25, 2021
Final prospectus, with the priceMay 27, 2021

Open IPO · From the cover of the final prospectus (424B5) filed May 27, 2021

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue22.0K02.56M4.29M2.76M394.0K85.0K
Cost of revenue3.64M5.24M3.92M3.01M16.0M14.5M
Gross profit-3.62M1.98M4.29M2.29M394.0K-14.4M
Research and development37.6M34.4M32.1M28.1M22.0M16.0M14.5M
Selling, general and administrative26.2M23.5M34.9M40.8M21.3M9.30M7.34M
Operating income-68.8M-61.0M-92.7M-62.1M-40.4M-24.7M-21.8M
Depreciation and amortization3.64M3.84M3.56M1.40M769.0K1.99M1.40M
EBITDA-65.1M-57.2M-89.2M-60.7M-39.7M-22.7M-20.4M
Interest expense3.92M11.0K88.0K0
Income before tax-61.4M-52.8M-83.4M-58.2M-55.3M-19.9M-21.2M
Income tax009.51M-12.4M11.0K150.0K
Net income-61.4M-52.8M-71.1M-58.2M-55.3M-19.9M-21.2M
Earnings per share, basic-2.73-12.03-16.01-2.23-19.00-4.55-15.57
Earnings per share, diluted-2.73-12.03-16.01-2.23-19.00

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents16.4M48.3M35.9M57.6M56.0M30.5M5.30M
Short-term investments040.9M025.0K12.5M
Receivables1.59M1.80M17.7M626.0K483.0K317.0K78.0K
Inventory335.0K3.29M2.60M25.0K
Current assets23.3M59.0M71.2M102.6M60.2M31.7M18.8M
Property, plant and equipment12.9M21.3M25.3M51.4M12.4M16.1M16.6M
Total assets51.2M97.8M119.5M180.8M96.7M48.3M35.8M
Accounts payable2.94M1.45M1.25M1.37M5.19M914.0K1.20M
Current liabilities14.0M13.1M12.7M18.1M14.5M4.87M4.31M
Total debt28.9M33.6M37.7M37.1M22.7M14.0M
Total liabilities45.6M47.1M52.6M53.5M36.3M107.1M17.9M
Shareholders' equity5.59M25.6M66.9M127.3M-111.5M-58.7M18.0M
Shares outstanding30.9M4.83M4.57M44.1M2.97M4.37M1.36M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-43.4M-41.4M-52.4M-34.9M-34.6M-24.2M-18.4M
Capital spending-196.0K-26.0K-12.0M-41.4M-5.54M-1.16M-2.00M
Free cash flow-43.6M-41.4M-64.4M-76.3M-40.2M-25.3M-20.4M
Cash from investing-184.0K34.0K30.1M-82.0M-5.54M11.4M3.75M
Cash from financing11.8M53.7M779.0K118.6M68.4M38.1M14.0M
Dividends paid-404.0K-5.17M-3.89K
Share buybacks512.0K196.0K
Change in cash-31.9M12.4M-21.5M1.70M28.3M25.2M5.80M

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 20, 2026Current reportSEC
144 · Notice of proposed saleNov 20, 2026Other filingsSEC
SCHEDULE 13D/A · Big-stake notice, amendedNov 18, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedNov 18, 2026Big-stake noticeSEC
8-K · Current reportNov 18, 2026Current reportSEC
10-Q · Quarterly reportNov 16, 2026Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 13, 2026Big-stake noticeSEC
8-K · Current reportNov 10, 2026Material contractSEC
8-K · Current reportOct 27, 2026Management or board changeSEC
8-K · Current reportOct 26, 2026Acquisition or disposalSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipOct 23, 2026Insider tradeSEC
4 · Change in ownershipOct 23, 2026Insider tradeSEC
8-K · Current reportOct 15, 2026Meeting outcomeSEC
DEFA14A · Additional proxy materialOct 13, 2026Meeting noticeSEC
8-K · Current reportOct 13, 2026Current reportSEC
EFFECT · Notice that a registration is effectiveSep 25, 2026Other filingsSEC
DEFM14ASep 24, 2026Meeting noticeSEC
424B3 · ProspectusSep 24, 2026Offer documentSEC
8-K · Current reportSep 24, 2026Management or board changeSEC
PRER14ASep 23, 2026Other filingsSEC
S-3/A · Registration statement, amendedSep 22, 2026Offer documentSEC
SCHEDULE 13D/A · Big-stake notice, amendedSep 11, 2026Big-stake noticeSEC
S-3/A · Registration statement, amendedSep 10, 2026Offer documentSEC
PRER14ASep 4, 2026Other filingsSEC
DEFA14A · Additional proxy materialSep 4, 2026Meeting noticeSEC
8-K · Current reportSep 4, 2026Material contractSEC
DEFA14A · Additional proxy materialSep 2, 2026Meeting noticeSEC
8-K · Current reportSep 2, 2026Material contractSEC
DEFA14A · Additional proxy materialAug 20, 2026Meeting noticeSEC
8-K · Current reportAug 20, 2026Material contractSEC
10-Q · Quarterly reportAug 14, 2026Quarterly reportSEC
ARS · Annual report to shareholdersJul 21, 2026Annual reportSEC
PREM14AJul 21, 2026Other filingsSEC
SCHEDULE 13D/A · Big-stake notice, amendedJul 16, 2026Big-stake noticeSEC
S-3/A · Registration statement, amendedJul 16, 2026Offer documentSEC
DEFA14A · Additional proxy materialJul 15, 2026Meeting noticeSEC
8-K · Current reportJul 15, 2026ResultsSEC
S-3 · Registration statementJun 18, 2026Offer documentSEC
DJun 3, 2026Other filingsSEC
8-K · Current reportMay 26, 2026Material contractSEC
10-Q · Quarterly reportMay 14, 2026Quarterly reportSEC
8-K · Current reportMay 14, 2026ResultsSEC
15-12GMay 8, 2026Other filingsSEC
SCHEDULE 13D/A · Big-stake notice, amendedMay 4, 2026Big-stake noticeSEC
424B5 · ProspectusMay 1, 2026Offer documentSEC
8-K · Current reportMay 1, 2026Material contractSEC
EFFECT · Notice that a registration is effectiveApr 30, 2026Other filingsSEC
EFFECT · Notice that a registration is effectiveApr 30, 2026Other filingsSEC
EFFECT · Notice that a registration is effectiveApr 30, 2026Other filingsSEC
EFFECT · Notice that a registration is effectiveApr 30, 2026Other filingsSEC
10-K/A · Annual report, amendedApr 29, 2026Annual reportSEC
S-8 · Registration statement for employee plansApr 24, 2026Offer documentSEC
S-8 POSApr 24, 2026Offer documentSEC
S-8 POSApr 24, 2026Offer documentSEC
S-8 POSApr 24, 2026Offer documentSEC
S-8 POSApr 24, 2026Offer documentSEC
POS AM · Amendment to an effective registrationApr 24, 2026Offer documentSEC
POS AM · Amendment to an effective registrationApr 24, 2026Offer documentSEC
POS AM · Amendment to an effective registrationApr 24, 2026Offer documentSEC
8-K12BApr 24, 2026Other filingsSEC
POS AM · Amendment to an effective registrationApr 24, 2026Offer documentSEC
SCHEDULE 13D/A · Big-stake notice, amendedApr 16, 2026Big-stake noticeSEC
8-K · Current reportApr 1, 2026Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 31, 2026Big-stake noticeSEC
10-K · Annual reportMar 27, 2026Annual reportSEC
8-K · Current reportMar 27, 2026ResultsSEC
8-K · Current reportMar 19, 2026Material contractSEC
4 · Change in ownershipMar 11, 2026Insider tradeSEC
4 · Change in ownershipMar 11, 2026Insider tradeSEC
4 · Change in ownershipFeb 3, 2026Insider tradeSEC
4 · Change in ownershipFeb 3, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 20, 2026Big-stake noticeSEC
8-K · Current reportDec 9, 2025Current reportSEC
10-Q · Quarterly reportNov 13, 2025Quarterly reportSEC
8-K · Current reportNov 13, 2025ResultsSEC
SCHEDULE 13D/A · Big-stake notice, amendedSep 2, 2025Big-stake noticeSEC
10-Q · Quarterly reportAug 7, 2025Quarterly reportSEC
8-K · Current reportAug 7, 2025ResultsSEC
4 · Change in ownershipJul 21, 2025Insider tradeSEC
3 · Initial statement of ownershipJul 21, 2025Insider tradeSEC
8-K · Current reportJul 18, 2025Management or board changeSEC
8-K · Current reportJun 30, 2025Meeting outcomeSEC
4 · Change in ownershipJun 27, 2025Insider tradeSEC
4 · Change in ownershipJun 27, 2025Insider tradeSEC
4 · Change in ownershipJun 27, 2025Insider tradeSEC
4 · Change in ownershipJun 27, 2025Insider tradeSEC
4 · Change in ownershipJun 27, 2025Insider tradeSEC
4 · Change in ownershipJun 27, 2025Insider tradeSEC
8-K · Current reportJun 18, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 7, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 6, 2025Quarterly reportSEC
8-K · Current reportMay 6, 2025ResultsSEC
ARS · Annual report to shareholdersApr 30, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 30, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 30, 2025Meeting noticeSEC
8-K · Current reportApr 28, 2025ResultsSEC
EFFECT · Notice that a registration is effectiveApr 1, 2025Other filingsSEC
EFFECT · Notice that a registration is effectiveApr 1, 2025Other filingsSEC
424B5 · ProspectusMar 31, 2025Offer documentSEC
CORRESP · Letter to the SECMar 27, 2025Other filingsSEC
CORRESP · Letter to the SECMar 27, 2025Other filingsSEC
UPLOAD · Letter from the SECMar 26, 2025Other filingsSEC
UPLOAD · Letter from the SECMar 26, 2025Other filingsSEC
8-K · Current reportMar 24, 2025Material contractSEC
S-3 · Registration statementMar 21, 2025Offer documentSEC
S-3 · Registration statementMar 21, 2025Offer documentSEC
10-K · Annual reportMar 20, 2025Annual reportSEC
8-K · Current reportMar 20, 2025ResultsSEC
SCHEDULE 13D · Big-stake noticeMar 17, 2025Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 17, 2025Big-stake noticeSEC
4 · Change in ownershipMar 14, 2025Insider tradeSEC
3 · Initial statement of ownershipMar 13, 2025Insider tradeSEC
SCHEDULE 13D · Big-stake noticeMar 13, 2025Big-stake noticeSEC
4 · Change in ownershipMar 12, 2025Insider tradeSEC
3 · Initial statement of ownershipMar 12, 2025Insider tradeSEC
4 · Change in ownershipMar 12, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
3 · Initial statement of ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
3 · Initial statement of ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 10, 2025Insider tradeSEC
4 · Change in ownershipMar 10, 2025Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 10, 2025Big-stake noticeSEC
8-K · Current reportMar 10, 2025Management or board changeSEC
S-8 · Registration statement for employee plansMar 7, 2025Offer documentSEC
8-K · Current reportMar 7, 2025Meeting outcomeSEC
8-K · Current reportFeb 25, 2025Management or board changeSEC
SCHEDULE 13G · Big-stake noticeFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeFeb 14, 2025Big-stake noticeSEC
4 · Change in ownershipFeb 6, 2025Insider tradeSEC
4 · Change in ownershipFeb 6, 2025Insider tradeSEC
8-K · Current reportFeb 6, 2025Management or board changeSEC
DEF 14A · Proxy statementJan 27, 2025Meeting noticeSEC
PRE 14A · Preliminary proxy statementJan 15, 2025Meeting noticeSEC
8-K · Current reportJan 6, 2025FinancingSEC
DDec 19, 2024Other filingsSEC
8-K · Current reportDec 16, 2024Current reportSEC
4 · Change in ownershipDec 11, 2024Insider tradeSEC
4 · Change in ownershipDec 10, 2024Insider tradeSEC
3 · Initial statement of ownershipDec 10, 2024Insider tradeSEC
4 · Change in ownershipDec 10, 2024Insider tradeSEC
3 · Initial statement of ownershipDec 10, 2024Insider tradeSEC
4 · Change in ownershipDec 10, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedDec 4, 2024Big-stake noticeSEC
8-K · Current reportDec 3, 2024Current reportSEC
144 · Notice of proposed saleDec 2, 2024Other filingsSEC
8-K · Current reportDec 2, 2024Material contractSEC
8-K · Current reportDec 2, 2024Current reportSEC
10-Q · Quarterly reportNov 14, 2024Quarterly reportSEC
8-K · Current reportNov 14, 2024ResultsSEC
8-K · Current reportOct 25, 2024Current reportSEC
8-K · Current reportSep 27, 2024Material contractSEC
10-Q · Quarterly reportAug 13, 2024Quarterly reportSEC
8-K · Current reportAug 13, 2024ResultsSEC
8-K · Current reportJul 17, 2024Current reportSEC
8-K · Current reportJul 16, 2024Material contractSEC
4 · Change in ownershipJul 12, 2024Insider tradeSEC
4 · Change in ownershipJul 12, 2024Insider tradeSEC
4 · Change in ownershipJul 12, 2024Insider tradeSEC
4 · Change in ownershipJul 12, 2024Insider tradeSEC
8-K · Current reportJul 12, 2024Meeting outcomeSEC
ARS · Annual report to shareholdersMay 29, 2024Annual reportSEC
DEFA14A · Additional proxy materialMay 29, 2024Meeting noticeSEC
DEF 14A · Proxy statementMay 29, 2024Meeting noticeSEC
PRE 14A · Preliminary proxy statementMay 17, 2024Meeting noticeSEC
8-K · Current reportMay 17, 2024Management or board changeSEC
3 · Initial statement of ownershipMay 9, 2024Insider tradeSEC
10-Q · Quarterly reportMay 9, 2024Quarterly reportSEC
8-K · Current reportMay 9, 2024ResultsSEC
8-K · Current reportMay 2, 2024Management or board changeSEC
10-K/A · Annual report, amendedApr 26, 2024Annual reportSEC
8-K · Current reportApr 26, 2024Management or board changeSEC
10-K · Annual reportMar 21, 2024Annual reportSEC
8-K · Current reportMar 21, 2024ResultsSEC
8-K · Current reportFeb 6, 2024Current reportSEC
4 · Change in ownershipFeb 2, 2024Insider tradeSEC
4 · Change in ownershipFeb 2, 2024Insider tradeSEC
4 · Change in ownershipFeb 2, 2024Insider tradeSEC
S-8 · Registration statement for employee plansJan 10, 2024Offer documentSEC
8-K · Current reportJan 5, 2024Current reportSEC
8-K · Current reportDec 22, 2023Current reportSEC
10-Q · Quarterly reportNov 13, 2023Quarterly reportSEC
8-K · Current reportNov 13, 2023ResultsSEC
424B3 · ProspectusNov 13, 2023Offer documentSEC
424B3 · ProspectusNov 13, 2023Offer documentSEC
8-K · Current reportNov 6, 2023Material contractSEC
EFFECT · Notice that a registration is effectiveNov 6, 2023Other filingsSEC
EFFECT · Notice that a registration is effectiveNov 6, 2023Other filingsSEC
POS AM · Amendment to an effective registrationNov 1, 2023Offer documentSEC

This page holds 200 of 375 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Senti Biosciences Holdings, Inc.’s releases · as of Nov 19, 2026

Common shares
1,165,313
Fully diluted
1,165,313

Fully diluted

LineSharesAs of
Common shares1,165,313Nov 19, 2026

Share count over time

CountShares
Nov 19, 20261,165,313
Nov 19, 2026
Nov 17, 2026

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard629K0.73%US$196KSep 30, 2026
Geode Capital177K0.21%US$55,136Sep 30, 2026
Two Sigma153K0.18%US$47,916Sep 30, 2026
Gts Securities LLC110K0.13%US$34,320Sep 30, 2026
Hrt Financial LP53,8270.06%US$16,000Sep 30, 2026
Virtu Financial LLC47,2710.06%US$15,000Sep 30, 2026
Menlo Ventures Management, L.P.35,7370.04%US$11,157Sep 30, 2026
Northern Trust32,1540.04%US$10,038Sep 30, 2026
Susquehanna23,1470.03%US$7,226Sep 30, 2026
UBS17,4020.02%US$5,430Sep 30, 2026
All 21 holders
HolderSharesOf the companyValueAs of
Citadel16,3650.02%US$5,109Sep 30, 2026
XTX Topco Ltd14,8850.02%US$4,647Sep 30, 2026
State Street10,0100.01%US$3,125Sep 30, 2026
Nuveen9,8190.01%US$3,019Sep 30, 2026
Tower Research Capital LLC (TRC)8,9590.01%US$2,797Sep 30, 2026
RBC4,015<0.01%US$1,000Sep 30, 2026
SBI Securities Co., Ltd.523<0.01%US$163Sep 30, 2026
BlackRock262<0.01%US$82Sep 30, 2026
Morgan Stanley160<0.01%US$50Sep 30, 2026
Barclays10<0.01%US$3Sep 30, 2026
Caitong International Asset Management Co., Ltd1<0.01%Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund369K0.43%US$406KJun 30, 2026
Vanguard Extended Market Index Fund169K0.20%US$185KJun 30, 2026
Fidelity Extended Market Index Fund95,8660.11%US$91,226May 31, 2026
Fidelity Nasdaq Composite Index Fund24,7980.03%US$23,598May 31, 2026
Fidelity Total Market Index Fund19,9910.02%US$19,023May 31, 2026
Fidelity Series Total Market Index Fund18,8010.02%US$17,891May 31, 2026

Big stakes

StakeStakeSharesDateFiling
Celadon Partners SPV 2454.60%25.7MSep 3, 2026Schedule 13D
New Enterprise Associates 15, L.P.9.70%8.78MNov 16, 2026Schedule 13D
Bayer HealthCare LLC6.90%6.14MNov 16, 2026Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Edward Mathers
Other companies: NeueHealth Inc (Director · Since at least Oct 2, 2025); MBX Biosciences, Inc. (Director · Since at least Sep 12, 2024); OnKure Therapeutics, Inc. (Director · Since at least Apr 8, 2021); Trevi Therapeutics, Inc. (Director · Since at least May 7, 2019); Rhythm Pharmaceuticals, Inc. (Director · Since at least Oct 4, 2017); Inozyme Pharma Inc (Director · Jul 23, 2020 – Jun 18, 2024 · Past); Akouos Inc (Director · Jun 25, 2020 – Dec 1, 2022 · Past); Mirum Pharmaceuticals, Inc. (Director · Jul 17, 2019 – Jun 2, 2022 · Past); Ra Pharmaceuticals Inc (Director · Jun 28, 2018 – Apr 2, 2020 · Past); Synlogic Inc (Director · Dec 29, 2017 – Jun 22, 2023 · Past)
Director · Since at least Jun 8, 2022
Mostafa Ronaghi
Other companies: Summit Therapeutics Inc. (Non-Executive Director · Since at least Apr 11, 2024); Seer, Inc. (Director · Feb 13, 2021 – Jun 14, 2023 · Past); Illumina, Inc. (SVP, Entrepreneurial Devlopmt · Apr 23, 2013 – Dec 10, 2020 · Past)
Chief Executive Officer, Director · May 25, 2021 – May 25, 2021 · Past
Kanya Rajangam
Other companies: Turnstone Biologics Corp. (Director · Jul 20, 2023 – Jun 3, 2024 · Past); Nkarta, Inc. (Chief Medical Officer · Jul 9, 2020 – Jan 14, 2022 · Past)
Pres. & Chief Med. & Dev. Off. · Since at least Jul 5, 2022
Brenda Cooperstone
Other companies: Lexeo Therapeutics, Inc. (Board Member · Since at least Nov 2, 2023)
Director · Since at least Jun 8, 2022
Deborah Knobelman
Other companies: Kronos Bio Inc (President & Interim CEO · Since at least Jun 3, 2024)
Chief Financial Officer · Jun 8, 2022 – Feb 1, 2024 · Past
Donald F Tang
Other companies: Vicarious Surgical, Inc. (Director · Since at least Jul 14, 2020)
Director · Since at least Dec 9, 2024
Fran Schulz
Other companies: Edap Tms SA (Director · Since at least Jan 1, 2026)
Director · Since at least Dec 9, 2024
John Harry Cross III
Other companies: Chanticleer Holdings Inc (Chief Financial Officer · Apr 1, 2020 – Dec 11, 2023 · Past)
Chief Financial Officer · Mar 3, 2025 – Mar 7, 2025 · Past
Bryan BaumDirector · Since at least Jul 18, 2025
Feng HsiungDirector · Since at least Mar 7, 2025
All 13 people
PersonSeat
Fran SchulzDirector · Since at least Dec 2, 2024
Jay CrossChief Financial Officer · Since at least Feb 25, 2025
Jenene ThomasChief Executive Officer · Since at least Jan 14, 2026

Open People

Log in to ask 6ix AI your own questions about Senti Biosciences Holdings, Inc.